[Treatment of Parkinson's disease with L-dopa. 77 cases].
D000328:Adult; D000367:Age Factors; D000368:Aged; D002318:Cardiovascular Diseases / Q000139:chemically induced; D002986:Clinical Trials as Topic; D004295:Dihydroxyphenylalanine / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006801:Humans; D008297:Male; D001523:Mental Disorders / Q000139:chemically induced; D008875:Middle Aged; D009069:Movement Disorders / Q000139:chemically induced / Q000188:drug therapy; D010300:Parkinson Disease / Q000188:drug therapy*; D010919:Placebos; D013997:Time Factors; D014202:Tremor / Q000188:drug therapy
D010919:Placebos; D004295:Dihydroxyphenylalanine
Traitement des syndromes parkinsoniens par la L-dopa. A propos de 77 observations.